Humanigen is taking action on the novel coronavirus outbreak. Refer to this page for the latest educational resources and information on lenzilumab as a therapeutic for cytokine storm resulting from COVID-19 infection

Follow us on Twitter to stay informed

Resources from Humanigen

FDA Approves Emergency IND Use of Humanigen’s Lenzilumab for Compassionate Use in COVID-19 Patients

Read the Full Press Release

Humanigen COVID-19 Presentation

PDF (2.4 MB)

  • Twitter

©2020 Humanigen, Inc.  All rights reserved